Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iressa in ER-/PgR- breast cancer
NCT00252811Phase 2Withdrawn
- Sponsor
- AstraZeneca
- Start
- Feb 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in breast cancer, sponsored by AstraZeneca. Planned start Feb 2004; status: withdrawn.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00252811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00252811.